154 related articles for article (PubMed ID: 29804387)
21. Direct antiviral treatment of chronic hepatitis C in heart transplant recipients.
Vitrone M; Andini R; Mattucci I; Maiello C; Atripaldi L; Durante-Mangoni E; Zampino R
Transpl Infect Dis; 2018 Feb; 20(1):. PubMed ID: 29139181
[TBL] [Abstract][Full Text] [Related]
22. Update on hepatitis C treatment: systematic review of clinical trials.
Jhaveri M; Procaccini N; Kowdley KV
Minerva Gastroenterol Dietol; 2017 Mar; 63(1):62-73. PubMed ID: 27768010
[TBL] [Abstract][Full Text] [Related]
23. Current challenges and the management of chronic hepatitis C in mainland China.
Duan Z; Jia JD; Hou J; Lou L; Tobias H; Xu XY; Wei L; Zhuang H; Pan CQ
J Clin Gastroenterol; 2014 Sep; 48(8):679-86. PubMed ID: 24921215
[TBL] [Abstract][Full Text] [Related]
24. Hepatitis C standards of care: A review of good practices since the advent of direct-acting antiviral therapy.
Lazarus JV; Picchio CA; Guy D; Aleman S; James C; Nava FA; Øvrehus A; Turnes J; Ward JW; Ustianowski A
Clin Res Hepatol Gastroenterol; 2021 Mar; 45(2):101564. PubMed ID: 33740477
[TBL] [Abstract][Full Text] [Related]
25. EFFECTIVE TREATMENT OF CHRONIC HEPATITIS C VIRUS INFECTIONS WITH DIRECT ACTING ANTIVIRALS IN PRISONS SYSTEM.
Vashakidze E; Imnadze T; Mikadze I
Georgian Med News; 2018 Jan; (274):112-116. PubMed ID: 29461238
[TBL] [Abstract][Full Text] [Related]
26. Hepatitis C virus related cirrhosis decreased as indication to liver transplantation since the introduction of direct-acting antivirals: A single-center study.
Ferrarese A; Germani G; Gambato M; Russo FP; Senzolo M; Zanetto A; Shalaby S; Cillo U; Zanus G; Angeli P; Burra P
World J Gastroenterol; 2018 Oct; 24(38):4403-4411. PubMed ID: 30344424
[TBL] [Abstract][Full Text] [Related]
27. Hepatitis C-A clinical review.
Wang LS; D'Souza LS; Jacobson IM
J Med Virol; 2016 Nov; 88(11):1844-55. PubMed ID: 27097298
[TBL] [Abstract][Full Text] [Related]
28. Public health impact of comprehensive hepatitis C screening and treatment in the French baby-boomer population.
Ethgen O; Sanchez Gonzalez Y; Jeanblanc G; Duguet A; Misurski D; Juday T
J Med Econ; 2017 Feb; 20(2):162-170. PubMed ID: 27590836
[TBL] [Abstract][Full Text] [Related]
29. [Recent advances in the treatment of hepatitis C in 2016].
Luo BF; Wei L
Zhonghua Gan Zang Bing Za Zhi; 2017 Mar; 25(3):175-180. PubMed ID: 28482403
[TBL] [Abstract][Full Text] [Related]
30. The removal of DAA restrictions in Europe - One step closer to eliminating HCV as a major public health threat.
Marshall AD; Pawlotsky JM; Lazarus JV; Aghemo A; Dore GJ; Grebely J
J Hepatol; 2018 Nov; 69(5):1188-1196. PubMed ID: 29959953
[TBL] [Abstract][Full Text] [Related]
31. Current treatment of chronic hepatitis C in China: Dilemma and potential problems.
Han QY; Liu ZW
World J Gastroenterol; 2016 May; 22(19):4615-8. PubMed ID: 27217693
[TBL] [Abstract][Full Text] [Related]
32. Treatment of Hepatitis C virus infection in Italy: A consensus report from an expert panel.
Viganò M; Perno CF; Craxì A;
Dig Liver Dis; 2017 Jul; 49(7):731-741. PubMed ID: 28456519
[TBL] [Abstract][Full Text] [Related]
33. Are we nearing the end in the fight against hepatitis C?
Chua JV; Kottilil S
Expert Rev Gastroenterol Hepatol; 2017 Jun; 11(6):499-500. PubMed ID: 28335650
[No Abstract] [Full Text] [Related]
34. Critical challenges and emerging opportunities in hepatitis C virus research in an era of potent antiviral therapy: Considerations for scientists and funding agencies.
Bartenschlager R; Baumert TF; Bukh J; Houghton M; Lemon SM; Lindenbach BD; Lohmann V; Moradpour D; Pietschmann T; Rice CM; Thimme R; Wakita T
Virus Res; 2018 Mar; 248():53-62. PubMed ID: 29477639
[TBL] [Abstract][Full Text] [Related]
35. Hepatitis C Virus Treatment in Children: A Challenge for Hepatitis C Virus Elimination.
El-Sayed MH; Indolfi G
Semin Liver Dis; 2020 Aug; 40(3):213-224. PubMed ID: 32526785
[TBL] [Abstract][Full Text] [Related]
36. HCV Drug Resistance Challenges in Japan: The Role of Pre-Existing Variants and Emerging Resistant Strains in Direct Acting Antiviral Therapy.
Chayama K; Hayes CN
Viruses; 2015 Oct; 7(10):5328-42. PubMed ID: 26473914
[TBL] [Abstract][Full Text] [Related]
37. Towards curative therapy of chronic viral hepatitis.
Bartenschlager R; Urban S; Protzer U
Z Gastroenterol; 2019 Jan; 57(1):61-73. PubMed ID: 30641605
[TBL] [Abstract][Full Text] [Related]
38. Is there a role for ribavirin in the era of hepatitis C virus direct-acting antivirals?
Feld JJ
Gastroenterology; 2012 May; 142(6):1356-9. PubMed ID: 22537443
[No Abstract] [Full Text] [Related]
39. Clinical outcome to interferon therapy in chronic hepatitis C: insights from mechanistic studies.
Beard MR
Antivir Ther; 2004 Oct; 9(5):637-9. PubMed ID: 15535401
[No Abstract] [Full Text] [Related]
40. The effect of sustained virological response by direct-acting antivirals on insulin resistance and diabetes mellitus in patients with chronic hepatitis C.
Adinolfi LE; Rinaldi L; Marrone A; Giordano M
Expert Rev Anti Infect Ther; 2018 Aug; 16(8):595-597. PubMed ID: 30047799
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
